Use of anti-tumor necrosis factor antibodies in rheumatoid arthritis.

Use of anti-tumor necrosis factor antibodies in rheumatoid arthritis.

Detalhes bibliográficos
Principais autores:	Feldmann, M, Elliott, M, Brennan, F, Maini, R
Formato:	Journal article
Idioma:	English
Publicado em:	1994

Registros relacionados

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.
por: Feldmann, M, et al.
Publicado em: (1997)

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.
por: Paleolog, E, et al.
Publicado em: (1996)

Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
por: Feldmann, M, et al.
Publicado em: (1997)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
por: Elliott, M, et al.
Publicado em: (1993)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
por: Elliot, M, et al.
Publicado em: (2008)

Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.
por: Maini, R, et al.
Publicado em: (1999)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
por: Maini, R, et al.
Publicado em: (1995)

Similarities in the mechanisms of action of pulse corticosteroids and anti-tumor necrosis factor alpha therapy in rheumatoid arthritis - Reply
por: Maini, R, et al.
Publicado em: (1998)

Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis.
por: Cope, A, et al.
Publicado em: (1994)

Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha.
por: Haworth, C, et al.
Publicado em: (1991)

Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
por: Brennan, F, et al.
Publicado em: (1995)

INCREASED EXPRESSION OF TUMOR-NECROSIS-FACTOR RECEPTORS ON CELLS ISOLATED FROM RHEUMATOID-ARTHRITIS SYNOVIAL JOINTS
por: Gibbons, D, et al.
Publicado em: (1992)

What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
por: Feldmann, M
Publicado em: (1996)

Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha.
por: Deleuran, B, et al.
Publicado em: (1992)

Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.
por: Feldmann, M, et al.
Publicado em: (1995)

Immunological intervention reveals reciprocal roles for tumor necrosis factor-alpha and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus.
por: Maini, R, et al.
Publicado em: (1994)

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.
por: Maini, R, et al.
Publicado em: (1998)

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
por: Lipsky, P, et al.
Publicado em: (2000)

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
por: Elliott, M, et al.
Publicado em: (1994)

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
por: Williams, R, et al.
Publicado em: (1992)

Rheumatoid arthritis.
por: Feldmann, M, et al.
Publicado em: (1996)

Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints.
por: Brennan, F, et al.
Publicado em: (1992)

Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis.
por: Chu, C, et al.
Publicado em: (1991)

ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
por: Feldmann, M, et al.
Publicado em: (2011)

Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis.
por: Ulfgren, A, et al.
Publicado em: (2000)

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.
por: Taylor, P, et al.
Publicado em: (2000)

Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.
por: Davis, D, et al.
Publicado em: (1997)

Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
por: Paleolog, E, et al.
Publicado em: (1998)

Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis.
por: Tak, P, et al.
Publicado em: (1996)

Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis.
por: Williams, R, et al.
Publicado em: (1994)

Role of cytokines in rheumatoid arthritis.
por: Feldmann, M, et al.
Publicado em: (1996)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
por: Maini, R, et al.
Publicado em: (1994)

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
por: Maini, R, et al.
Publicado em: (1993)

Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy.
por: Brennan, F, et al.
Publicado em: (1997)

TNF alpha is an effective therapeutic target for rheumatoid arthritis.
por: Feldmann, M, et al.
Publicado em: (1995)

TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.
por: Maini, R, et al.
Publicado em: (1997)

Heterogeneity of anticitrullinated peptide antibodies and response to anti-tumor necrosis factor agents in rheumatoid arthritis.
por: Fisher, B, et al.
Publicado em: (2012)

Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy
por: Antonio Julià, et al.
Publicado em: (2021-04-01)

TNF alpha as a therapeutic target in rheumatoid arthritis.
por: Feldmann, M, et al.
Publicado em: (1994)

Role of pro-inflammatory cytokines in rheumatoid arthritis.
por: Brennan, F, et al.
Publicado em: (1998)